PPARG and chronic obstructive pulmonary disease: Previous studies about the potent anti-inflammatory properties of the PPARG agonists suggest the use of PPARG ligands in COPD therapy [12,30,31] and association of PPARG gene polymorphisms with the development of asthma has been reported [11].